At a preclinical level, projects must rely upon strong literature evidence. Projects supported by clear scientific data deriving from in vitro, ex vivo, or animal models will be prioritized.
Molecular targets identified in clinical trials (up to Phase II clinical trial) shall also be considered, but the compounds under investigation must be first in the class and not available as marketed drugs
|1||You are an academic researcher, a research group, a small biotech or a technology transfer office? You have a project on new molecular target at an early stage of development (preclinical up to clinical phase II)
Submit your research project in a 30 line short industry like form!
Click here to see an example of project posted.
Note: All submitted information should not be confidential. Our partner will review all submitted information for a first evaluation. When asking for confidential data, our partner will agree a Confidential Disclosure Agreement (CDA) with you.
|2||Your project will be reviewed by Biowebspin’s team to see if any information is missing and then send to our partner R&D team that will assess it and come back to you if theyre are interested.|
|3||Your research project will also be promoted on the online partnering platform dedicated to novel targets.
You will be connected as soon as an industrial shows interest in your project.
|This program is free of charge and your information will be treated as secure and private.|
Check if one program will fit your researches for industrial collaboration and funding.
THE PROJECT MANAGER
THE PROJECT CONTACT
Partnership and Business Director
As a Swiss International company, Biowebspin has high standard security and privacy system. Biowebspin is in accordance with the Federal Data Protection and Information Commissioner.
Check here the terms and conditions of the matchmaking service of Biowebspin.